Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,926–5,950 of 7,816 matching trials · page 238 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Efficacy of 1072nm Infrared Stimulation on Executive Functioning in Dementia NCT01059877 1072nm infrared Photobiomodulation; Photobiomodulation SIMULATED Runs in: United States · 1 site |
NA other |
COMPLETED | 11 | Quietmind Foundation OTHER |
2018-09-27 |
|
Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198 NCT02226835 Runs in: United States · 1 site |
NA other |
TERMINATED | 33 | National Eye Institute (NEI) NIH |
2018-09-27 |
|
Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides NCT03635879 MCTprocal medical food; Milk/tricaprilin oil blend; AC-1207; AC-120... |
PHASE1 other |
WITHDRAWN | 0 | Cerecin INDUSTRY |
2018-09-27 |
|
Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology NCT03681574 Placebo Group; GABA 15mg/kg Group; GABA 30mg/kg Group Runs in: Brazil · 1 site |
PHASE4 other |
COMPLETED | 135 | Hospital Infantil Albert Sabin OTHER |
2018-09-27 |
|
Feasibility Study of Neurofeedback Training for Older Adults With Mild Cognitive Impairment NCT03686839 SMR neurofeedback training to MCI Runs in: France · 1 site |
NA other |
COMPLETED | 22 | Fabienne Marlats OTHER |
2018-09-27 |
|
Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases. NCT02750982 Laughter Therapy Runs in: United States · 1 site |
NA other |
COMPLETED | 24 | Brown, Theodore R., M.D., MPH OTHER |
2018-09-26 |
|
Improving Staff Attitudes and Care for People With Dementia: eLearning NCT03208517 Improving Wellbeing and Health for People with Dementia (WHELD) e-l... Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 282 | King's College London OTHER |
2018-09-26 |
|
A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease NCT01428453 250mg rilapladib; placebo Runs in: Bulgaria; Canada; Germany; Italy; Norway; Spain; Sweden · 30 sites |
PHASE2 other |
COMPLETED | 124 | GlaxoSmithKline INDUSTRY |
2018-09-24 |
|
Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia NCT00233454 Midostaurin Runs in: United States · 3 sites |
PHASE2 other |
COMPLETED | 26 | Jason Robert Gotlib OTHER |
2018-09-20 |
|
Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) NCT01852110 MK-7622; Placebo; AChEI |
PHASE2 other |
TERMINATED | 240 | Merck Sharp & Dohme LLC INDUSTRY |
2018-09-18 |
|
[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) NCT02562989 [18F]MK-6240, ~185 MBq; [18F]MK-6240, ~160 MBq |
PHASE1 other |
COMPLETED | 13 | Merck Sharp & Dohme LLC INDUSTRY |
2018-09-18 |
|
Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979. NCT02793232 PF-06751979 single dose; Placebo single dose; PF-06751979 multiple ... Runs in: Belgium · 1 site |
PHASE1 other |
COMPLETED | 46 | Pfizer INDUSTRY |
2018-09-17 |
|
Prognosis of Anxiety in Intensive Care Unit NCT02355626 Runs in: France · 1 site |
NA other |
COMPLETED | 391 | Assistance Publique - Hôpitaux de Paris OTHER |
2018-09-14 |
|
A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS) NCT03438604 Donepezil TDS Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 24 | Corium, Inc. INDUSTRY |
2018-09-14 |
|
Webnovela for Hispanic Dementia Family Caregivers NCT02489110 Webnovela; Information Runs in: United States · 1 site |
NA other |
COMPLETED | 150 | Photozig, Inc. INDUSTRY |
2018-09-13 |
|
Determinants of Cognitive Impairment Among Geriatrics NCT03669536 Runs in: Indonesia · 1 site |
NA other |
UNKNOWN | 80 | Tarumanagara University OTHER |
2018-09-13 |
|
Supporting Family Carers to People Living With Symptoms of Dementia at Home up to the End of Life NCT03666611 Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 30 | University of Manchester OTHER |
2018-09-12 |
|
A Pilot Study of Rehabilitation Among Intensive Care Unit (ICU) Survivors: the RETURN Trial NCT00715494 Cognitive, physical, and functional rehabilitation Runs in: United States · 1 site |
NA other |
COMPLETED | 24 | Vanderbilt University OTHER |
2018-09-11 |
|
Corticolimbic Degeneration and Treatment of Dementia NCT00768261 Memantine (Namenda®); Donepezil (Aricept®) |
PHASE4 symptomatic-cholinergic |
COMPLETED | 39 | Washington University School of Medicine OTHER |
2018-09-11 |
|
Use of Telemedicine in Collaboration Between a Psychogeriatric Unit and Nursing Homes NCT01217268 Training in person centered care by supervision using video-conference Runs in: Norway · 1 site |
NA other |
WITHDRAWN | 0 | Sykehuset Innlandet HF OTHER |
2018-09-07 |
|
Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease NCT02162251 Donepezil Hydrochloride Runs in: Japan · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 3,482 | Eisai Co., Ltd. INDUSTRY |
2018-09-07 |
|
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice NCT02162264 Donepezil Hydrochloride Runs in: Japan · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 8,662 | Eisai Co., Ltd. INDUSTRY |
2018-09-07 |
|
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut) NCT02992327 Runs in: United States · 1 site |
NA other |
COMPLETED | 100 | HealthPartners Institute OTHER |
2018-09-07 |
|
Fortified Foods in Older Inpatients NCT03176030 Fortified Foods Runs in: United Kingdom · 1 site |
NA other |
WITHDRAWN | 0 | University Hospital Southampton NHS Foundation Trust OTHER |
2018-09-07 |
|
Mild Cognitive Impairment, Use of qEEG as a Prognostic Marker NCT03659643 EEG with SPR analysis Runs in: Iceland · 1 site |
NA other |
UNKNOWN | 300 | Jon Snaedal OTHER |
2018-09-06 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial